These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16277697)

  • 61. Benefits of anticitrullinated peptides examination in rheumatoid arthritis.
    Belakova G; Manka V; Zanova E; Racay P
    Niger J Clin Pract; 2018 Oct; 21(10):1380-1383. PubMed ID: 30297575
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Anti-CCP biosensors in rheumatoid arthritis.
    Karami P; Gholamin D; Fathi F; Afsar T; Johari-Ahar M
    Clin Chim Acta; 2024 Jul; 561():119767. PubMed ID: 38857671
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis.
    Zendman AJ; van Venrooij WJ; Pruijn GJ
    Rheumatology (Oxford); 2006 Jan; 45(1):20-5. PubMed ID: 16188946
    [No Abstract]   [Full Text] [Related]  

  • 64. Low level (below cutoff) of anti-cyclic citrullinated peptide test results in diagnosis of rheumatoid arthritis in a high-risk population.
    Kim DA; Kim TY
    J Rheumatol; 2010 Jan; 37(1):208. PubMed ID: 20040646
    [No Abstract]   [Full Text] [Related]  

  • 65. Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritis.
    Burgers LE; van Steenbergen HW; Ten Brinck RM; Huizinga TW; van der Helm-van Mil AH
    Ann Rheum Dis; 2017 Oct; 76(10):1751-1754. PubMed ID: 28606964
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Systematic review: accuracy of anti-citrullinated Peptide antibodies for diagnosing rheumatoid arthritis.
    Whiting PF; Smidt N; Sterne JA; Harbord R; Burton A; Burke M; Beynon R; Ben-Shlomo Y; Axford J; Dieppe P
    Ann Intern Med; 2010 Apr; 152(7):456-64; W155-66. PubMed ID: 20368651
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Does early rheumatoid arthritis exist?
    Dixon WG; Symmons DP
    Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):37-53. PubMed ID: 15588970
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Circulating plasmablasts/plasmacells as a source of anticitrullinated protein antibodies in patients with rheumatoid arthritis.
    Kerkman PF; Rombouts Y; van der Voort EI; Trouw LA; Huizinga TW; Toes RE; Scherer HU
    Ann Rheum Dis; 2013 Jul; 72(7):1259-63. PubMed ID: 23625975
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: the best diagnostic tool but also a great interest in prognosis].
    Lequerré T; Richez C
    Rev Prat; 2012 Oct; 62(8):1088-9. PubMed ID: 23227605
    [No Abstract]   [Full Text] [Related]  

  • 70. Rheumatologic diagnostic serology: tests which test clinicians.
    Wong ML
    N Z Med J; 2004 Oct; 117(1203):U1095. PubMed ID: 15477919
    [No Abstract]   [Full Text] [Related]  

  • 71. Production of anti-CCP antibodies and matrix metalloproteinase-3 by human rheumatoid arthritis synovial tissues using SCID mice.
    Iwaki-Egawa S; Matsuno H; Ogawa Y; Watanabe Y
    Ann Rheum Dis; 2005 Jul; 64(7):1094-5. PubMed ID: 15958770
    [No Abstract]   [Full Text] [Related]  

  • 72. Diagnostic accuracy of immunoassays for the detection of antibodies to citrullinated proteins.
    Bizzaro N; Tampoia M
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):16-20. PubMed ID: 18270852
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical interest of autoantibodies directed against citrullinated peptides in Indian patients with rheumatoid arthritis.
    Goëb V
    Indian J Med Sci; 2009 Mar; 63(3):89-91. PubMed ID: 19359775
    [No Abstract]   [Full Text] [Related]  

  • 74. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.
    Aggarwal R; Liao K; Nair R; Ringold S; Costenbader KH
    Arthritis Rheum; 2009 Nov; 61(11):1472-83. PubMed ID: 19877103
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Arthralgia plus positive treatment of rheumatoid arthritis - no].
    Specker Ch
    Dtsch Med Wochenschr; 2014 Sep; 139(37):1843. PubMed ID: 25181001
    [No Abstract]   [Full Text] [Related]  

  • 76. [Antibodies against citrullinated peptides in clinical practice and research].
    Engelmann R; Müller-Hilke B
    Z Rheumatol; 2009 Aug; 68(6):485-90. PubMed ID: 19578861
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antibodies to citrullinated proteins: pathogenic and diagnostic significance.
    Holers VM
    Curr Rheumatol Rep; 2007 Oct; 9(5):396-400. PubMed ID: 17915095
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The impact of rheumatoid factor and ACPA on bone erosion in rheumatoid arthritis.
    Hecht C; Schett G; Finzel S
    Ann Rheum Dis; 2015 Jan; 74(1):e4. PubMed ID: 25326218
    [No Abstract]   [Full Text] [Related]  

  • 79. "ACPA" in Rheumatoid Arthritis: From Population-based Data to Personalized Medicine.
    Ménard HA
    J Rheumatol; 2015 May; 42(5):733-5. PubMed ID: 25934875
    [No Abstract]   [Full Text] [Related]  

  • 80. Anti-citrullinated peptide/protein antibodies and structural prognosis of rheumatoid arthritis: quantity versus quality.
    Meyer O
    J Rheumatol; 2012 Apr; 39(4):675-6. PubMed ID: 22467946
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.